drugset / Trial / NCT03969680
Mesenchymal Stem Cell Transplantation for Osteoarthritis
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to explore the efficacy and safety of autologous bone marrow-derived mesenchymal stem cells (BMSCs) plus autologous platelet rich plasma (PRP) in the treatment of severe knee osteoarthritis.
Timeline
- Start
- 2019-07-08
- Primary completion
- 2023-10-30
- Completion
- 2023-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMSCs | Cell therapy | — | Intramuscular |
| Comparator | Platelet Rich Plasma | Other / unclassified | 3 ml | Intramuscular |